Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Conen

Showing results (111-120 of 363) with videos related to

Pageof 37
Sort By:
Circulation. Arrhythmia and Electrophysiology|June 16, 2020
Canakinumab After Electrical Cardioversion in Patients With Persistent Atrial Fibrillation: A Pilot Randomized TrialPhilipp Krisai, Steffen Blum, Renate B Schnabel, et al.
Journal of the American Heart Association|May 3, 2014
Predisposing factors associated with development of persistent compared with paroxysmal atrial fibrillationRoopinder K Sandhu, David Conen, Usha B Tedrow, et al.
European Heart Journal|August 5, 2019
Thromboembolic events around the time of cardioversion for atrial fibrillation in patients receiving antiplatelet treatment in the ACTIVE trialsWilliam F McIntyre, Stuart J Connolly, Jia Wang, et al.
Journal of the American College of Cardiology|May 22, 2010
The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (women's health study)Usha B Tedrow, David Conen, Paul M Ridker, et al.
BMC Cardiovascular Disorders|September 30, 2020
C-reactive protein for prediction of atrial fibrillation recurrence after catheter ablationPascal B Meyre, Christian Sticherling, Florian Spies, et al.
Scientific Reports|February 1, 2022
Biomarkers associated with rhythm status after cardioversion in patients with atrial fibrillationPascal B Meyre, Stefanie Aeschbacher, Steffen Blum, et al.
Clinical Endocrinology|April 14, 2015
Plasma levels of glucagon-like peptide 1 and markers of obesity among young and healthy adultsJan Gerrit van der Stouwe, Stefanie Aeschbacher, Philipp Krisai, et al.
Annals of Medicine|August 19, 2016
Heart rate, heart rate variability and inflammatory biomarkers among young and healthy adultsStefanie Aeschbacher, Tobias Schoen, Laura Dörig, et al.
Heart (British Cardiac Society)|November 1, 2016
Risk factors for premature ventricular contractions in young and healthy adultsMirco von Rotz, Stefanie Aeschbacher, Matthias Bossard, et al.
Clinical Cardiology|March 17, 2018
Stroke-prevention strategies in North American patients with atrial fibrillation: The GLORIA-AF registry programWilliam F McIntyre, David Conen, Brian Olshansky, et al.
Pageof 37

Showing results (111-120 of 363) with videos related to

Sort By:
Pageof 37
Circulation. Arrhythmia and Electrophysiology|June 16, 2020
Canakinumab After Electrical Cardioversion in Patients With Persistent Atrial Fibrillation: A Pilot Randomized TrialPhilipp Krisai, Steffen Blum, Renate B Schnabel, et al.
Journal of the American Heart Association|May 3, 2014
Predisposing factors associated with development of persistent compared with paroxysmal atrial fibrillationRoopinder K Sandhu, David Conen, Usha B Tedrow, et al.
European Heart Journal|August 5, 2019
Thromboembolic events around the time of cardioversion for atrial fibrillation in patients receiving antiplatelet treatment in the ACTIVE trialsWilliam F McIntyre, Stuart J Connolly, Jia Wang, et al.
Journal of the American College of Cardiology|May 22, 2010
The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (women's health study)Usha B Tedrow, David Conen, Paul M Ridker, et al.
BMC Cardiovascular Disorders|September 30, 2020
C-reactive protein for prediction of atrial fibrillation recurrence after catheter ablationPascal B Meyre, Christian Sticherling, Florian Spies, et al.
Scientific Reports|February 1, 2022
Biomarkers associated with rhythm status after cardioversion in patients with atrial fibrillationPascal B Meyre, Stefanie Aeschbacher, Steffen Blum, et al.
Clinical Endocrinology|April 14, 2015
Plasma levels of glucagon-like peptide 1 and markers of obesity among young and healthy adultsJan Gerrit van der Stouwe, Stefanie Aeschbacher, Philipp Krisai, et al.
Annals of Medicine|August 19, 2016
Heart rate, heart rate variability and inflammatory biomarkers among young and healthy adultsStefanie Aeschbacher, Tobias Schoen, Laura Dörig, et al.
Heart (British Cardiac Society)|November 1, 2016
Risk factors for premature ventricular contractions in young and healthy adultsMirco von Rotz, Stefanie Aeschbacher, Matthias Bossard, et al.
Clinical Cardiology|March 17, 2018
Stroke-prevention strategies in North American patients with atrial fibrillation: The GLORIA-AF registry programWilliam F McIntyre, David Conen, Brian Olshansky, et al.
Pageof 37